Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

PT-141 Oral Taste: Administration Route Comparison

Subcutaneous Injection (Standard) 29–40% at 1.75mg dose 20–40 minutes 4–12 hours Most common route; taste correlates with plasma Cmax Intranasal (Off-Label) 15–25% at equivalent doses 10–20 minutes (faster onset) 3–8 hours Faster absorption, shorter duration;

This comparison does not assign a generated winner or score.

  • Subcutaneous Injection (Standard)
  • 29–40% at 1.75mg dose
  • 20–40 minutes
  • 4–12 hours
  • Most common route; taste correlates with plasma Cmax
  • Intranasal (Off-Label)
  • 15–25% at equivalent doses
  • 10–20 minutes (faster onset)
  • 3–8 hours
  • Faster absorption, shorter duration; less GI nausea but higher dysgeusia rate per mg
  • Oral Tablets (Experimental)
  • 5–10% reported
  • Variable, 60–120 minutes
  • 2–6 hours
  • Poor bioavailability (<10%); taste less common due to low systemic exposure
  • Sublingual (Rare)
  • 35–50% reported
  • 15–30 minutes
  • 6–10 hours
  • Direct mucosal absorption; higher local receptor activation in oral tissues
More references

Related material